Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system (Q40049499)

16 September 2017

title

Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system (English)

1 reference

Simian immunodeficiency virus

16 September 2017

0 references

0 references

author name string

Tang Y

series ordinal

1

1 reference

16 September 2017

Swanstrom R

series ordinal

2

1 reference

16 September 2017

language of work or name

English

0 references

publication date

26 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

372

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

72-84

1 reference

Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

HIV vaccines: new frontiers in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

A novel approach for producing lentiviruses that are limited to a single cycle of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

p21-activated kinase 1 plays a critical role in cellular activation by Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Association of Cancer With AIDS-Related Immunosuppression in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Structure--function relationships in HIV-1 Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Molecular mechanisms of cellular transformation by HTLV-1 Tax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Retroviral restriction by APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

DNA deamination mediates innate immunity to retroviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

An African primate lentivirus (SIVsm) closely related to HIV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Alphavirus replicon approach to promoterless analysis of IRES elements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Chromatin remodeling and modification during HIV-1 Tat-activated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Identification of the Nef-associated kinase as p21-activated kinase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

HIV-1 integration in the human genome favors active genes and local hotspots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Replication-defective HIV as a vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Antibody neutralization and escape by HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Transcription start regions in the human genome are favored targets for MLV integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

Mutational analysis of the human immunodeficiency virus type 1 Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.023

7 January 2021

10.1016/J.VIROL.2007.09.023

Identifiers

DOI

1 reference

16 September 2017

1 reference